Program for the prevention of vascular-related amputations

Logo ampere

  • Improving access to optimal medical diagnostics and therapy in non-metropolitan regions and low-resource settings.

  • Establishment of a supraregional medical care amputation registry

  • Conducting studies on arteriogenesis

Within the last decades, the treatment of vascular diseases has improved enormously and many treatment approaches have been revolutionized. The current concept is described as “endovascular-first approach”: Primarily, non-surgical therapeutic measures of vascular occlusions, vascular constrictions or vascular bulges (aneurysms) are used. Only when these do not show sufficient therapeutic success are combination interventions (so-called hybrid interventions) or vascular surgery measures applied.

However, access to these optimized therapeutic procedures for female patients is highly unevenly distributed regionally:

  • the therapy options are not known in all regions
  • the nearest specialist is often far away from the place of residence
  • the waiting time for an appointment can be weeks to months

As a result, the benefits of modern vascular medicine are far from accessible to all patients.

EFVM is committed to reducing or eliminating the total number of amputations in the long term and providing patients with access to advanced endovascular therapies. To achieve this goal, it is first necessary to assess the current status of vascular amputations.

These data are collected in collaboration with health insurers, clinics, physicians and patients – with a focus on non-metropolitan regions and low-resource settings. All amputations performed are then recorded in the Ampere Registry as a supraregional medical care registry. Through a subsequent scientific evaluation of the data, the Ampere Registry will serve as a basis to sustainably improve vascular health in the aforementioned regions. New and personalized treatment strategies can be offered to patients in this way.